Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 1 5Phase 3 4Phase 1/2 3Phase NA 2Phase 2/3 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 25Cyclophosphamide 23venetoclax 16Methotrexate 15Daunorubicin 14Dexamethasone 13Vincristine 11Etoposide 11Azacitidine 10Idarubicin 9Decitabine 9Busulfan 9fludarabine 8Radiotherapy 8Prednisone 8Stem Cell Transplantation 7Mercaptopurine 7Doxorubicin 7Asparaginase 7pegaspargase 6fludarabine phosphate 6blinatumomab 6Granulocyte Colony-Stimulating Factor 6Gemtuzumab 6Filgrastim 6Thiotepa 5Methylprednisolone 5Dasatinib 5Whole-Body Irradiation 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Hematopoietic Stem Cell Transplantation × Other hematologic neoplasm × Clear all
NCT04708054 2026-02-19

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
324 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00630565 2024-01-29

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Masonic Cancer Center, University of Minnesota

Phase 2/3 Terminated
12 enrolled 12 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡